VOLITIONRX LTD (VNRX)

US Markets · Healthcare · Medical - Diagnostics & Research

$1.39 -22.35%

Closing price as of 2026-06-08 · Source: TEK2day Finance

1-Year Price History -32.2% over period

Key Metrics

Market Cap

$24.5M

About VOLITIONRX LTD

VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.